Do you want to read an article? Please log in or register.
A case report of unusually long lag time between immunotactoid glomerulopathy (itg) diagnosis and diffuse large B-cell lymphoma (DLBCL) development
Lymphoma
Related content
Lymphoma
CD19-Directed CAR T Cells Treatment in a Patient With Refractory DLBCL and CNS Involvement
healthbook TIMS Oncology Hematology
Ring A, Müller A
doi: 10.36000/hbT.OH.2019.01.005
Lymphoma
Anti-CD19 CAR T Cells in CNS Diffuse Large-B-Cell Lymphoma
N Engl J Med.
Abramson JS, McGree B, Noyes S, Plummer, S, Wong C, Chen Y, Palmer E, Albertson T, Ferry JA, Arrillaga-Romany IC
doi: 10.1056/NEJMc1704610.
Lymphoma
Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study
Lancet Oncol.
Chiappella A, Martelli M, Angelucci E, Brusamolino E, Evangelista A, Carella AM, Stelitano C, Rossi G, Balzarotti M, Merli F, Gaidano G, Pavone V, Rigacci L, Zaja F, D'Arco A, Cascavilla N, Russo E, Castellino A, Gotti M, Congiu AG, Cabras MG, Tucci A, Agostinelli C, Ciccone G, Pileri SA, Vitolo U
doi: 10.1016/S1470-
Lymphoma
Single-agent MOR208 salvage and maintenance therapy in a patient with refractory/relapsing diffuse large B-cell lymphoma: a case report.
J Med Case Rep.
Jurczak W, Bryk AH, Mensah P, Gałązka K, Trofimiuk-Müldner M, Wyrobek Ł, Sawiec A, Skotnicki AB
doi: 10.1186/s13256-016-0875-x.
Lymphoma
Cerebellar large B-cell lymphoma: a case report
doi: 10.1186/s13256-018-1880-z.
Lymphoma
Primary Cutaneous Anaplastic Lymphoma Kinase-Positive Large B-Cell Lymphoma
Am J Dermatopathol.
Kempf W, Torricelli R, Zettl A, Zimmermann AK, Berisha A, Ghielmini M
doi: 10.1097/DAD.
Lymphoma
Hodgkin’s Lymphoma after Autologous Stem-Cell Transplantation: Effective Consolidation with Brentuximab Vedotin
healthbook Times Oncology Hematology
Schmidt A
doi: 10.36000/hbT.OH.2020.06.025
Lymphoma
Modern management of relapsed and refractory aggressive B-cell lymphoma: A perspective on the current treatment landscape and patient selection for CAR T-cell therapy
★ 1
Recommended by
Prof. Dr Christoph Renner, Faculty Member
Blood Rev.
Bachanova V, Perales MA, Abramson JS
doi: 10.1016/j.blre.2019.100640.
Lymphoma
Crizotinib in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma in the setting of renal insufficiency: a case report
J Med Case Rep.
Kothari S, Ud-Din N, Lisi M, Coyle T
doi: 10.1186/s13256-016-0963-y.